TY - CHAP
T1 - Global sensitivity, feasibility, and flexibility analysis of continuous pharmaceutical manufacturing processes
AU - Wang, Zilong
AU - Ierapetritou, Marianthi
N1 - Publisher Copyright:
© 2018 Elsevier B.V.
PY - 2018
Y1 - 2018
N2 - Simulation models for continuous pharmaceutical manufacturing processes have been developed and adapted as a powerful computer-aided tool to facilitate the process development. Accordingly, process analysis methods have also been implemented to obtain a more extensive process knowledge. In this book chapter, we gave an overview of the recent advances on two aspects of process analysis methods based on simulations: (1) global sensitivity analysis, and (2) feasibility and flexibility analysis methods. Global sensitivity analysis extracts the process knowledge in a “forward” manner: within certain ranges of the inputs, how these inputs can contribute to the variability in the output. On the other hand, feasibility and flexibility analysis evaluates the process in a “backward” manner: given specified ranges (i.e., process constraints) on the output, what is the design space of the inputs within which a process can always remain feasible. These two process analysis strategies together can strengthen the process understanding in developing a pharmaceutical process.
AB - Simulation models for continuous pharmaceutical manufacturing processes have been developed and adapted as a powerful computer-aided tool to facilitate the process development. Accordingly, process analysis methods have also been implemented to obtain a more extensive process knowledge. In this book chapter, we gave an overview of the recent advances on two aspects of process analysis methods based on simulations: (1) global sensitivity analysis, and (2) feasibility and flexibility analysis methods. Global sensitivity analysis extracts the process knowledge in a “forward” manner: within certain ranges of the inputs, how these inputs can contribute to the variability in the output. On the other hand, feasibility and flexibility analysis evaluates the process in a “backward” manner: given specified ranges (i.e., process constraints) on the output, what is the design space of the inputs within which a process can always remain feasible. These two process analysis strategies together can strengthen the process understanding in developing a pharmaceutical process.
KW - Adaptive sampling
KW - Continuous pharmaceutical manufacturing
KW - Feasibility analysis
KW - Sensitivity analysis
KW - Surrogate
UR - http://www.scopus.com/inward/record.url?scp=85055180900&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055180900&partnerID=8YFLogxK
U2 - 10.1016/B978-0-444-63963-9.00008-7
DO - 10.1016/B978-0-444-63963-9.00008-7
M3 - Chapter
AN - SCOPUS:85055180900
T3 - Computer Aided Chemical Engineering
SP - 189
EP - 213
BT - Computer Aided Chemical Engineering
PB - Elsevier B.V.
ER -